BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 88 filers reported holding BIODELIVERY SCIENCES INTL IN in Q2 2016. The put-call ratio across all filers is 2.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $33,000 | -23.3% | 14,472 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $43,000 | 0.0% | 14,472 | 0.0% | 0.00% | -25.0% |
| Q3 2017 | $43,000 | +19.4% | 14,472 | +12.5% | 0.00% | +33.3% |
| Q2 2017 | $36,000 | 0.0% | 12,859 | -32.2% | 0.00% | 0.0% |
| Q1 2017 | $36,000 | +2.9% | 18,959 | -6.4% | 0.00% | -25.0% |
| Q4 2016 | $35,000 | -57.3% | 20,259 | -33.3% | 0.00% | -60.0% |
| Q3 2016 | $82,000 | +12.3% | 30,359 | -2.5% | 0.01% | 0.0% |
| Q2 2016 | $73,000 | -20.7% | 31,137 | +9.3% | 0.01% | -23.1% |
| Q1 2016 | $92,000 | -31.9% | 28,484 | +0.9% | 0.01% | -31.6% |
| Q4 2015 | $135,000 | -82.3% | 28,233 | -79.4% | 0.02% | -84.3% |
| Q3 2015 | $762,000 | -0.3% | 136,963 | +42.8% | 0.12% | +15.2% |
| Q2 2015 | $764,000 | -17.8% | 95,926 | +8.3% | 0.10% | -14.6% |
| Q1 2015 | $930,000 | -16.8% | 88,560 | -4.8% | 0.12% | -16.9% |
| Q4 2014 | $1,118,000 | – | 92,982 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,595,855 | $10,929,000 | 10.61% |
| Broadfin Capital, LLC | 4,300,066 | $18,103,000 | 3.35% |
| 1492 Capital Management LLC | 778,483 | $3,277,000 | 3.20% |
| Avoro Capital Advisors LLC | 7,424,867 | $31,259,000 | 1.30% |
| Rubric Capital Management LP | 2,590,288 | $10,905,000 | 1.00% |
| Eversept Partners, LP | 708,020 | $2,980,764 | 0.92% |
| KNOTT DAVID M | 517,507 | $2,179,000 | 0.92% |
| Nantahala Capital Management | 4,846,167 | $20,402,000 | 0.76% |
| Grandeur Peak Global Advisors, LLC | 1,180,075 | $4,968,000 | 0.54% |
| EMERALD ADVISERS, LLC | 2,084,685 | $8,777,000 | 0.41% |